Home LiteratureArticle Details
PMID: 15013948 Published · ppublish English Journal Article

Incidence of breast cancer in Norway and Sweden during introduction of nationwide screening: prospective cohort study.

BMJ (Clinical research ed.) ·Vol. 328 ·No. 7445 ·2004-04-17 ·Pages 921-4

Zahl PH, Strand BH, Maehlen J

Abstract

To determine whether any increase in the incidence of breast cancer in women detected by mammography is compensated for by a drop in the incidence after age 69, years when women are no longer invited for screening. Population based cohort study of incidence of breast cancer during the introduction of nationwide screening programmes. Norway and Sweden. All women aged above 30 years (1.4 and 2.9 million, respectively, in 2000). Changes in age specific incidence rates of invasive breast cancer associated with the introduction of the screening programmes. As a result of screening the recorded incidence of breast cancer in women aged 50-69 years increased by 54% in Norway and 45% in Sweden. There was no corresponding decline in incidence after the age of 69 years. Without screening one third of all invasive breast cancers in the age group 50-69 years would not have been detected in the patients' lifetime. This level of overdiagnosis is larger than previously reported.

MeSH Terms
Adult Age Distribution Aged Breast Neoplasms/epidemiology Cohort Studies Female Humans Incidence Mass Screening Middle Aged Norway/epidemiology Prospective Studies Sweden/epidemiology
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Zahl Per-Henrik
Norwegian Institute of Public Health, PO Box 4404 Nydalen, N-0403 Oslo, Norway.
Strand Bjørn Heine
Maehlen Jan
References (8)
8 references, click to expand
  1. Implementation of screening as a public health policy: issues in design and evaluation.
    J Med Screen. 1999;6(4):209-16 PMID: 10693068
  2. Cochrane review on screening for breast cancer with mammography.
    Lancet. 2001 Oct 20;358(9290):1340-2 PMID: 11684218
  3. Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends.
    J Natl Cancer Inst. 2002 Jul 3;94(13):981-90 PMID: 12096083
  4. Evaluation of breast cancer incidence: is the increase due entirely to mammographic screening?
    Cancer Causes Control. 1999 Oct;10(5):333-7 PMID: 10530601
  5. Women need better information about routine mammography.
    BMJ. 2003 Jul 12;327(7406):101-3 PMID: 12855532
  6. Extra incidence caused by mammographic screening.
    Lancet. 1994 Apr 16;343(8903):979 PMID: 7909035
  7. Breast cancer screening in Navarra: interpretation of a high detection rate at the first screening round and a low rate at the second round.
    Int J Cancer. 1997 Nov 14;73(4):464-9 PMID: 9389557
  8. Clinical practice. Mammographic screening for breast cancer.
    N Engl J Med. 2003 Apr 24;348(17):1672-80 PMID: 12711743
Article Info
Journal
BMJ (Clinical research ed.)
Abbr.
BMJ
ISSN
1756-1833
Published
2004-04-17
Epub
2004-00-10
Pages
921-4
Language
English
Region
England
NLM ID
8900488
PMCID
PMC390204
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com